|
US479739A
(en)
*
|
|
1892-07-26 |
|
dimond |
|
US3096248A
(en)
*
|
1959-04-06 |
1963-07-02 |
Rexall Drug & Chemical Company |
Method of making an encapsulated tablet
|
|
US3406178A
(en)
*
|
1964-02-04 |
1968-10-15 |
Monsanto Chem Australia Ltd |
Preparation of 2-substituted benzimidazoles
|
|
US3362956A
(en)
*
|
1965-08-19 |
1968-01-09 |
Sterling Drug Inc |
1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
|
|
US4200641A
(en)
*
|
1976-12-21 |
1980-04-29 |
Janssen Pharmaceutica, N.V. |
1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
|
|
IL57569A0
(en)
|
1978-06-20 |
1979-10-31 |
Synthelabo |
Phenylpiperazine derivative,their preparation and pharmaceutical compositions containing them
|
|
DE3000979A1
(de)
*
|
1980-01-12 |
1981-07-23 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
|
|
DE3126703A1
(de)
|
1981-07-07 |
1983-01-27 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Bromhexin-retardform und verfahren zu ihrer herstellung
|
|
JPS58134033A
(ja)
|
1982-02-02 |
1983-08-10 |
Fujisawa Pharmaceut Co Ltd |
医薬組成物
|
|
IT1176613B
(it)
*
|
1984-08-14 |
1987-08-18 |
Ravizza Spa |
Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
|
|
IE58370B1
(en)
|
1985-04-10 |
1993-09-08 |
Lundbeck & Co As H |
Indole derivatives
|
|
GB8607294D0
(en)
*
|
1985-04-17 |
1986-04-30 |
Ici America Inc |
Heterocyclic amide derivatives
|
|
HUT43600A
(en)
*
|
1985-06-22 |
1987-11-30 |
Sandoz Ag |
Process for production of new thiazole derivatives and medical compound containing those
|
|
DE3620643A1
(de)
|
1985-06-22 |
1987-01-22 |
Sandoz Ag |
Thiazole, ihre herstellung und verwendung
|
|
GB8601160D0
(en)
|
1986-01-17 |
1986-02-19 |
Fujisawa Pharmaceutical Co |
Heterocyclic compounds
|
|
US5036088A
(en)
*
|
1986-06-09 |
1991-07-30 |
Pfizer Inc. |
Antiallergy and antiinflammatory agents, compositions and use
|
|
JPH0784462B2
(ja)
*
|
1986-07-25 |
1995-09-13 |
日清製粉株式会社 |
ベンゾイミダゾ−ル誘導体
|
|
US4968508A
(en)
*
|
1987-02-27 |
1990-11-06 |
Eli Lilly And Company |
Sustained release matrix
|
|
US4792452A
(en)
*
|
1987-07-28 |
1988-12-20 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
GB8830312D0
(en)
|
1988-12-28 |
1989-02-22 |
Lundbeck & Co As H |
Heterocyclic compounds
|
|
US4954503A
(en)
*
|
1989-09-11 |
1990-09-04 |
Hoechst-Roussel Pharmaceuticals, Inc. |
3-(1-substituted-4-piperazinyl)-1H-indazoles
|
|
WO1992002215A1
(en)
|
1990-08-09 |
1992-02-20 |
Massachusetts Institute Of Technology |
Method for treating the premenstrual or late luteal phase syndrome
|
|
CA2071488C
(en)
|
1990-08-24 |
1996-05-07 |
Kazuto Kobayashi |
Base for film-coating pharmaceuticals and method for preparing same
|
|
NZ241613A
(en)
*
|
1991-02-27 |
1993-06-25 |
Janssen Pharmaceutica Nv |
Highlighting intagliations in tablets
|
|
SE9100860D0
(sv)
*
|
1991-03-22 |
1991-03-22 |
Kabi Pharmacia Ab |
New use
|
|
FR2675800A1
(fr)
|
1991-04-26 |
1992-10-30 |
Rhone Poulenc Rorer Sa |
Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
|
|
FI934894A0
(fi)
|
1991-05-07 |
1993-11-05 |
Merck & Co Inc |
Fibrinogenreceptorantagonister
|
|
IT1251144B
(it)
*
|
1991-07-30 |
1995-05-04 |
Boehringer Ingelheim Italia |
Derivati del benzimidazolone
|
|
US5407686A
(en)
*
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
|
DE4216364A1
(de)
|
1991-12-14 |
1993-11-25 |
Thomae Gmbh Dr K |
Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5225417A
(en)
*
|
1992-01-21 |
1993-07-06 |
G. D. Searle & Co. |
Opioid agonist compounds
|
|
US5492907A
(en)
*
|
1992-12-09 |
1996-02-20 |
The United States Of America As Represented By The Department Of Health & Human Services |
Antipsychotic composition and method of treatment
|
|
DE69429768T2
(de)
|
1993-04-05 |
2002-09-19 |
Competitive Technologies, Inc. |
Diagnose und behandlung von erektilen funktionsstörungen
|
|
FR2707294B1
(fr)
*
|
1993-07-06 |
1995-09-29 |
Pf Medicament |
Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
|
|
GB9401090D0
(en)
|
1994-01-21 |
1994-03-16 |
Glaxo Lab Sa |
Chemical compounds
|
|
JP2860604B2
(ja)
|
1994-06-14 |
1999-02-24 |
ファイザー インク． |
中枢ドーパミン作動活性を有するベンズイミダゾロン誘導体
|
|
CN1083265C
(zh)
|
1994-08-23 |
2002-04-24 |
史密斯克莱·比奇曼公司 |
改进的含有布洛芬和可待因的药物配方
|
|
DE69531476T2
(de)
|
1994-09-12 |
2004-06-09 |
Lilly Industries Ltd., Basingstoke |
Serotonergische Modulatoren
|
|
JPH08143476A
(ja)
|
1994-11-18 |
1996-06-04 |
Japan Tobacco Inc |
薬物放出制御膜及び固形製剤
|
|
FR2727682A1
(fr)
*
|
1994-12-02 |
1996-06-07 |
Pf Medicament |
Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament
|
|
US5552412A
(en)
*
|
1995-01-09 |
1996-09-03 |
Pfizer Inc |
5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
|
|
US5883094A
(en)
*
|
1995-04-24 |
1999-03-16 |
Pfizer Inc. |
Benzimidazolone derivatives with central dopaminergic activity
|
|
US5854290A
(en)
*
|
1995-09-21 |
1998-12-29 |
Amy F. T. Arnsten |
Use of guanfacine in the treatment of behavioral disorders
|
|
US6083947A
(en)
*
|
1996-01-29 |
2000-07-04 |
The Regents Of The University Of California |
Method for treating sexual dysfunctions
|
|
GB9613423D0
(en)
|
1996-06-26 |
1996-08-28 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
|
US5916916A
(en)
*
|
1996-10-10 |
1999-06-29 |
Eli Lilly And Company |
1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods
|
|
DE69729950T2
(de)
|
1996-11-06 |
2005-07-28 |
Wockhardt Europe Ltd. |
Arzneimittel-Zuführsystem mit verzögerter Freisetzung für säurelabile Arzneistoffe
|
|
EP0942728A1
(en)
*
|
1996-12-02 |
1999-09-22 |
MERCK SHARP & DOHME LTD. |
Use of nk-1 receptor antagonists for treating sexual dysfunction
|
|
US5859246A
(en)
|
1997-01-30 |
1999-01-12 |
Neurogen Corporation |
1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
|
|
GB9706089D0
(en)
|
1997-03-24 |
1997-05-14 |
Scherer Ltd R P |
Pharmaceutical composition
|
|
US20040023948A1
(en)
*
|
1997-03-24 |
2004-02-05 |
Green Richard David |
Fast-dispersing dosage form containing 5-HT1 agonists
|
|
SK284690B6
(sk)
*
|
1997-06-11 |
2005-09-08 |
The Procter And Gamble Company |
Ústna dávkovacia forma na zvýšenie ochrany horného tráviaceho traktu
|
|
ATE241341T1
(de)
*
|
1997-09-10 |
2003-06-15 |
Takeda Chemical Industries Ltd |
Stabilisierte pharmazeutische zusammensetzung
|
|
SE9703375D0
(sv)
|
1997-09-18 |
1997-09-18 |
Astra Ab |
A new combination
|
|
CH692199A8
(fr)
*
|
1997-10-09 |
2002-06-14 |
Cermol S.A. |
Composes pyridiques et compositions pharmaceutique
|
|
JP3724157B2
(ja)
*
|
1997-10-30 |
2005-12-07 |
コニカミノルタホールディングス株式会社 |
映像観察装置
|
|
FR2775188B1
(fr)
*
|
1998-02-23 |
2001-03-09 |
Lipha |
Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
|
|
AU4068599A
(en)
|
1998-05-20 |
1999-12-06 |
Schering Corporation |
Combination of phentolamine and cyclic gmp phosphodiesterase inhibitors for the treatment of sexual dysfunction
|
|
AU3891299A
(en)
|
1998-05-21 |
1999-12-06 |
Eli Lilly And Company |
Combination therapy for treatment of depression
|
|
US20020151543A1
(en)
*
|
1998-05-28 |
2002-10-17 |
Sepracor Inc. |
Compositions and methods employing R (-) fluoxetine and other active ingredients
|
|
AU742425B2
(en)
|
1998-06-11 |
2002-01-03 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
|
US6068846A
(en)
*
|
1998-08-05 |
2000-05-30 |
Melaleuca, Incorporated |
Methods and materials for treating depression and mood disorder
|
|
EP0982030A3
(en)
|
1998-08-17 |
2000-05-10 |
Pfizer Products Inc. |
2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
|
|
UA67802C2
(uk)
|
1998-10-23 |
2004-07-15 |
Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. |
Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
|
|
WO2000028993A1
(en)
*
|
1998-11-19 |
2000-05-25 |
Nortran Pharmaceuticals, Inc. |
Serotonin ligands as pro-erectile compounds
|
|
US6680071B1
(en)
*
|
1999-03-03 |
2004-01-20 |
R. P. Scherer Technologies, Inc. |
Opioid agonist in a fast dispersing dosage form
|
|
WO2000063189A1
(en)
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
|
|
EP1173168A2
(en)
|
1999-04-28 |
2002-01-23 |
Respiratorius AB |
Compound for use as a medicament for treatment of disorders involving bronchocontraction
|
|
IT1312310B1
(it)
|
1999-05-07 |
2002-04-15 |
Recordati Ind Chimica E Farma |
Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale
|
|
US6579968B1
(en)
|
1999-06-29 |
2003-06-17 |
Palatin Technologies, Inc. |
Compositions and methods for treatment of sexual dysfunction
|
|
US20030055070A1
(en)
|
1999-07-01 |
2003-03-20 |
Wilma Harrison |
Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of selective serotonin reuptake inhibitor (SSR) induced sexual dysfunction
|
|
US6346548B1
(en)
|
1999-08-16 |
2002-02-12 |
Cephalon, Inc. |
Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
|
|
IT1313625B1
(it)
*
|
1999-09-22 |
2002-09-09 |
Boehringer Ingelheim Italia |
Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
|
|
DE19961334A1
(de)
|
1999-12-17 |
2001-06-21 |
Roehm Gmbh |
Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere
|
|
NZ520975A
(en)
*
|
2000-02-24 |
2004-03-26 |
Upjohn Co |
New drug combinations containing a norepinephrine reuptake inhibitor and an antimuscarinic agent for treating nervous system disorders
|
|
IL152781A0
(en)
|
2000-06-28 |
2003-06-24 |
Pfizer Prod Inc |
Melanocortin receptor ligands
|
|
US6960597B2
(en)
|
2000-06-30 |
2005-11-01 |
Orth-Mcneil Pharmaceutical, Inc. |
Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
|
|
US20020052370A1
(en)
|
2000-07-06 |
2002-05-02 |
Barber Christopher Gordon |
Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
|
|
US20040198706A1
(en)
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US6586435B2
(en)
|
2000-09-19 |
2003-07-01 |
Boehringer Ingelheim Pharma Kg |
Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
|
|
ES2273891T3
(es)
|
2000-09-19 |
2007-05-16 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG |
Nuevos derivados de bencimidazolona que presentan actividad en los receptores de serotonina y dopamina.
|
|
US6521623B1
(en)
|
2000-09-19 |
2003-02-18 |
Boehringer Ingelheim Pharma Kg |
N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
|
|
WO2002024661A2
(en)
|
2000-09-19 |
2002-03-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
|
|
CA2429383A1
(en)
|
2000-11-22 |
2002-05-30 |
Abbott Laboratories |
Selective dopamine d4 receptor agonists for treating sexual dysfunction
|
|
GB0105893D0
(en)
|
2001-03-09 |
2001-04-25 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
GB0106446D0
(en)
|
2001-03-15 |
2001-05-02 |
Vernalis Res Ltd |
Chemical compounds
|
|
EA006154B1
(ru)
|
2001-03-28 |
2005-10-27 |
Пфайзер Инк. |
N-фенпропилциклопентил-замещенные производные глутарамида в качестве nep ингибиторов при fsad
|
|
PT1256343E
(pt)
|
2001-05-11 |
2006-11-30 |
Jurgen K Beck |
Flibaserina para o tratamento de perturbações do movimento extrapiramidais
|
|
US6627646B2
(en)
*
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
|
AU2002320494B2
(en)
|
2001-07-18 |
2006-06-29 |
Merck Sharp & Dohme Corp. |
Bridged piperidine derivatives as melanocortin receptor agonists
|
|
CA2455987C
(en)
|
2001-07-30 |
2010-06-29 |
Neotherapeutics, Inc. |
Tetrahydroindolone and purine derivatives linked to arylpiperazines
|
|
US7183410B2
(en)
*
|
2001-08-02 |
2007-02-27 |
Bidachem S.P.A. |
Stable polymorph of flibanserin
|
|
RS50742B
(sr)
|
2001-08-02 |
2010-08-31 |
Bidachem S.P.A. |
Stabilni polimorf flibanserina, postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova
|
|
US20030060475A1
(en)
|
2001-08-10 |
2003-03-27 |
Boehringer Ingelheim Pharma Kg |
Method of using flibanserin for neuroprotection
|
|
DE10138273A1
(de)
|
2001-08-10 |
2003-02-27 |
Boehringer Ingelheim Pharma |
Arzneimittel mit neuroprotektiver Wirkung
|
|
HUP0202719A3
(en)
|
2001-08-21 |
2006-01-30 |
Pfizer Prod Inc |
Pharmaceutical compositions for the treatment of female sexual dysfunctions
|
|
DE10149674A1
(de)
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
|
UA78974C2
(en)
|
2001-10-20 |
2007-05-10 |
Boehringer Ingelheim Pharma |
Use of flibanserin for treating disorders of sexual desire
|
|
DE10209982A1
(de)
|
2002-03-07 |
2003-09-25 |
Boehringer Ingelheim Pharma |
Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
|
|
JP3919788B2
(ja)
|
2002-05-22 |
2007-05-30 |
ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
フリバンセリン多形ａを含む新規医薬組成物
|
|
US20040048877A1
(en)
*
|
2002-05-22 |
2004-03-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions containing flibanserin
|
|
EP1551393A4
(en)
|
2002-07-30 |
2010-06-16 |
Peter Migaly |
COMBINATION OF THERAPY FOR DEPRESSION, PREVENTION OF SUICIDE AND VARIOUS MEDICAL AND PSYCHIATRIC DISORDERS
|
|
US20040116532A1
(en)
*
|
2002-09-13 |
2004-06-17 |
Craig Heacock |
Pharmaceutical formulations of modafinil
|
|
US20040132697A1
(en)
*
|
2002-11-06 |
2004-07-08 |
Pfizer Inc. |
Treatment of female sexual dysfunction
|
|
GB0225908D0
(en)
|
2002-11-06 |
2002-12-11 |
Pfizer Ltd |
Treatment of female sexual dysfunction
|
|
US20040147581A1
(en)
*
|
2002-11-18 |
2004-07-29 |
Pharmacia Corporation |
Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
|
|
US20040193452A1
(en)
*
|
2003-01-06 |
2004-09-30 |
Laura Berman |
Method and system for computerized sexual function assessment of female users
|
|
WO2004069339A1
(en)
|
2003-01-29 |
2004-08-19 |
Psychogenics Inc. |
Treatment for attention-deficit hyperactivity disorder
|
|
US20050037983A1
(en)
*
|
2003-03-11 |
2005-02-17 |
Timothy Dinan |
Compositions and methods for the treatment of depression and other affective disorders
|
|
US20050065158A1
(en)
|
2003-07-16 |
2005-03-24 |
Pfizer Inc. |
Treatment of sexual dysfunction
|
|
EP1653966A1
(en)
|
2003-07-16 |
2006-05-10 |
Pfizer Limited |
Treatment of sexual dysfunction
|
|
EP1510133A1
(en)
*
|
2003-09-01 |
2005-03-02 |
Belovo S.A., Egg Science & Technology |
Balanced oil composition
|
|
WO2005025562A1
(en)
|
2003-09-11 |
2005-03-24 |
Xenoport, Inc. |
Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
|
|
WO2005044238A1
(en)
|
2003-11-07 |
2005-05-19 |
Ranbaxy Laboratories Limited |
Modified release solid dosage form of amphetamine salts
|
|
NZ551340A
(en)
|
2004-04-22 |
2010-10-29 |
Boehringer Ingelheim Int |
Pharmaceutical composition comprising flibanserin and a melanocortin agonist for the treatment of premenstrual disorder or sexual aversion disorder
|
|
US20050239798A1
(en)
|
2004-04-22 |
2005-10-27 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Method for the treatment of premenstrual and other female sexual disorders
|
|
US20060014757A1
(en)
|
2004-07-14 |
2006-01-19 |
Boehringer Ingelheim Pharmaceuticals |
Method for the treatment of anorexia nervosa
|
|
US20060025420A1
(en)
|
2004-07-30 |
2006-02-02 |
Boehringer Ingelheimn International GmbH |
Pharmaceutical compositions for the treatment of female sexual disorders
|
|
JP2008511569A
(ja)
*
|
2004-09-03 |
2008-04-17 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
注意欠如活動過多障害の治療方法
|
|
JP2008516909A
(ja)
|
2004-10-18 |
2008-05-22 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
前立腺及び下部泌尿生殖路の病気を治療するためのβ−３アゴニストの使用
|
|
JP2008531714A
(ja)
|
2005-03-04 |
2008-08-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
不安障害の治療用及び／又は予防用の医薬組成物
|
|
WO2006096439A2
(en)
*
|
2005-03-04 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
|
|
CA2599721A1
(en)
|
2005-03-04 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of depression
|
|
CA2608249A1
(en)
*
|
2005-05-06 |
2006-11-16 |
Boehringer Ingelheim International Gmbh |
Method for the treatment of drug abuse with flibanserin
|
|
US20060258640A1
(en)
*
|
2005-05-13 |
2006-11-16 |
Boehringer Ingelheim International Gmbh |
Use of Flibanserin in the treatment of chronic pain
|
|
US20060264511A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Boehringer Ingelheim International Gmbh |
Method for the treatment of drug-induced sexual dysfunction
|
|
JP2008540672A
(ja)
|
2005-05-19 |
2008-11-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
病状に起因する性的機能不全の治療方法
|
|
EP2502621A1
(en)
|
2005-06-27 |
2012-09-26 |
Valeant International (Barbados) SRL |
Crystalline forms of bupropion HBr
|
|
JP2009503020A
(ja)
|
2005-08-03 |
2009-01-29 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
肥満症の治療におけるフリバンセリンの使用
|
|
WO2007022325A2
(en)
|
2005-08-16 |
2007-02-22 |
Wionics Research |
Packet detection
|
|
HU227490B1
(en)
|
2005-08-26 |
2011-07-28 |
Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag |
Sustained release pharmaceutical preparation containing carvedilol
|
|
US20080275082A1
(en)
|
2005-09-30 |
2008-11-06 |
Jeffrey Brum |
Pharmaceutical Composition
|
|
JP2009513604A
(ja)
*
|
2005-10-29 |
2009-04-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
|
|
US20070123540A1
(en)
*
|
2005-10-29 |
2007-05-31 |
Angelo Ceci |
Sexual desire enhancing medicaments comprising benzimidazolone derivatives
|
|
US20070105869A1
(en)
|
2005-11-08 |
2007-05-10 |
Stephane Pollentier |
Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
|
|
CN101410093A
(zh)
|
2006-01-27 |
2009-04-15 |
欧兰德股份有限公司 |
包含弱碱性药物和有机酸的药物递送系统
|
|
CA2641917A1
(en)
*
|
2006-02-18 |
2007-08-23 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
|
|
CA2642101A1
(en)
*
|
2006-02-20 |
2007-08-30 |
Boehringer Ingelheim International Gmbh |
Benzimidazolone derivatives for the treatment of urinary incontinence
|
|
US20090247546A1
(en)
*
|
2006-02-28 |
2009-10-01 |
Boehringer Ingelheim International Gmbh |
Treatment of Prevention of Valvular Heart Disease with Flibanserin
|
|
JP2009536176A
(ja)
|
2006-05-09 |
2009-10-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
閉経後の性的欲求障害の治療のためのフリバンセリンの使用
|
|
WO2008000760A1
(en)
|
2006-06-30 |
2008-01-03 |
Boehringer Ingelheim International Gmbh |
Flibanserin for the treatment of urinary incontinence and related diseases
|
|
JP2009543839A
(ja)
|
2006-07-14 |
2009-12-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
女性の性的障害を治療するためのフリバンセリンの使用
|
|
WO2008006839A2
(en)
|
2006-07-14 |
2008-01-17 |
Boehringer Ingelheim International Gmbh |
Combinations of flibanserin with caffeine, process for their preparation and use thereof as medicaments
|
|
CL2007002214A1
(es)
*
|
2006-08-14 |
2008-03-07 |
Boehringer Ingelheim Int |
Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
|
|
AU2007286288A1
(en)
*
|
2006-08-14 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Formulations of flibanserin and method for manufacturing the same
|
|
EP2056797A2
(en)
|
2006-08-25 |
2009-05-13 |
Boehringer Ingelheim International GmbH |
Controlled release system and method for manufacturing the same
|
|
ATE524446T1
(de)
|
2006-12-20 |
2011-09-15 |
Boehringer Ingelheim Int |
Sulfatierte benzimidazolon-derivate mit gemischter serotonin-rezeptor-affinität
|
|
US20100093754A1
(en)
|
2007-03-28 |
2010-04-15 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders
|
|
US8486452B2
(en)
|
2007-07-20 |
2013-07-16 |
Mylan Pharmaceuticals Inc. |
Stabilized tolterodine tartrate formulations
|
|
UY31335A1
(es)
|
2007-09-12 |
2009-04-30 |
|
Tratamiento de sintomas vasomotores
|
|
CA2686480A1
(en)
|
2008-12-15 |
2010-06-15 |
Boehringer Ingelheim International Gmbh |
New salts
|